Nobesity

Company Overview

Snapshot

Founded in September 2005 by Amnon Engelberg and Dr. Erella Pines, Nobesity operates with 1–10 employees. The company has raised a total of $1.18M across five funding rounds. Nobesity has secured multiple grants, including support from the Office of the Chief Scientist in December 2013 and December 2012.

Business overview

Nobesity is a Health Tech & Life Sciences company focused on developing products for obesity prevention. Its core product, SlowBite, is a proprietary device designed to be inserted between the teeth to gently restrict mouth opening during eating. This behavioral training tool aims to help overweight and obese individuals develop healthier eating habits by promoting slower consumption of smaller amounts. Nobesity complements this device with dietary and nutritional information, serving B2C, B2B2C, and B2B markets globally, particularly within the healthcare sector for patients and providers.

Company Intelligence Q&A

What is Nobesity's primary product?

Nobesity's primary product is SlowBite, a proprietary device designed to be inserted between the teeth to gently restrict the amount a user's mouth can open while eating, serving as a behavioral training tool for healthier eating habits.

When was Nobesity founded and by whom?

Nobesity was founded in September 2005 by Amnon Engelberg and Dr. Erella Pines.

What is the total capital raised by Nobesity?

Nobesity has raised a total of $1.18M across five funding rounds.

Has Nobesity received any grants?

Yes, Nobesity received a grant from the Office of the Chief Scientist in December 2013 and another in December 2012.

What markets does Nobesity target?

Nobesity targets global markets, operating in B2C, B2B2C, and B2B business models, with a focus on patients and providers within the healthcare sector.